Clinical trial
The Impact of Intermittent Malaria Treatment Administered Through the EPI Scheme on Malaria Morbidity in Mozambican Children
NCT00209794 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Intermittent Malaria Treatment Administered Through the EPI Scheme on Malaria Morbidity in Mozambican Children
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2002
- Completion date
- December 31, 2005
- Enrollment
- 1,498
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.